Pedro Cascales. Universidad de Murcia. Hospital Clínico Universitario Virgen de la Arrixaca. Murcia, Spain

ESGO Moderator TBC

• An update on treatment of peritoneal metastasis of endometrial cancer and rare histologies of epithelial ovarian cancer (clear cell, mucinous adenocarcinoma, carcinosarcoma)
  Álvaro Tejerizo. Hospital Universitario 12 de Octubre. Madrid, Spain
  
• When and how to surgically treat recurrent ovarian cancer? From selection criteria to use of HIPEC
  Jean Marc Classe. Institut de Cancérologie de l’Ouest, Nantes, France
• Less is more or more is more? Surgical decision-making during interval cytoreduction of ovarian cancer treated with neoadjuvant chemotherapy
  Nikolaos Thomakos. “Alexandra” Hospital, National and Kapodistrian University of Athens. Athens, Greece
  
• Does PIPAC have a role in the management of recurrent, unresectable peritoneal metastases of ovarian cancer?
  Thanh Dellinger. City of Hope Comprehensive Cancer Center. Duarte, California, USA